| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.879 | 0.004 | 0.879 | Aldehyde oxidase inhibitor | 0.194 0.108 CID_18654381 | ||
| 0.808 | 0.01 | 0.808 | Caspase 9 stimulant | 0.788 0.013 CID_18654381 | ||
| 0.717 | 0.006 | 0.717 | 5 Hydroxytryptamine release stimulant | 0.563 0.018 CID_18654381 | ||
| 0.682 | 0.005 | 0.682 | Superoxide dismutase inhibitor | |||
| 0.668 | 0.003 | 0.668 | Peroxidase inhibitor | |||
| 0.654 | 0.003 | 0.654 | Alcohol oxidase inhibitor | 0.081 0.024 CID_18654381 | ||
| 0.614 | 0.006 | 0.614 | GABA C receptor rho-3 antagonist | |||
| 0.608 | 0.01 | 0.672 | 5 Hydroxytryptamine release inhibitor | 0.672 0.005 CID_18654381 | CID_18654381 | |
| 0.565 | 0.023 | 0.736 | Cholesterol antagonist | 0.736 0.006 CID_18654381 | CID_18654381 | |
| 0.552 | 0.012 | 0.707 | Free radical scavenger | 0.707 0.005 CID_18654381 | CID_18654381 | |
| 0.532 | 0.004 | 0.532 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.538 | 0.016 | 0.762 | Antioxidant | 0.762 0.005 CID_18654381 | CID_18654381 | |
| 0.533 | 0.019 | 0.652 | Histamine release inhibitor | 0.652 0.006 CID_18654381 | CID_18654381 | |
| 0.529 | 0.016 | 0.529 | Caspase 3 stimulant | 0.453 0.029 CID_18654381 | ||
| 0.521 | 0.012 | 0.521 | Amyloid beta aggregation inhibitor | 0.257 0.056 CID_18654381 | ||
| 0.517 | 0.022 | 0.517 | Calcium channel L-type activator | |||
| 0.552 | 0.06 | 0.709 | Apoptosis agonist | 0.709 0.029 CID_18654381 | CID_18654381 | |
| 0.493 | 0.004 | 0.493 | Cystathionine beta-synthase inhibitor | 0.413 0.005 CID_18654381 | ||
| 0.481 | 0.008 | 0.481 | Tubulin antagonist | |||
| 0.477 | 0.005 | 0.477 | 5 Hydroxytryptamine uptake stimulant | 0.214 0.127 CID_18654381 | ||
| 0.472 | 0.008 | 0.472 | Calcium channel activator | 0.277 0.116 CID_18654381 | ||
| 0.473 | 0.034 | 0.473 | Vasodilator, peripheral | 0.45 0.041 CID_18654381 | ||
| 0.468 | 0.048 | 0.468 | 15-Lipoxygenase inhibitor | |||
| 0.427 | 0.008 | 0.745 | Amylase inhibitor | 0.745 0.003 CID_18654381 | CID_18654381 | |
| 0.429 | 0.013 | 0.429 | Anesthetic general | 0.405 0.016 CID_18654381 | ||
| 0.441 | 0.03 | 0.441 | 12-Lipoxygenase inhibitor | |||
| 0.46 | 0.051 | 0.751 | Transcription factor NF kappa B inhibitor | 0.751 0.016 CID_18654381 | CID_18654381 | |
| 0.411 | 0.011 | 0.592 | Melanin inhibitor | 0.592 0.004 CID_18654381 | CID_18654381 | |
| 0.423 | 0.025 | 0.455 | Hypoxia-inducible factor 1 alpha inhibitor | 0.455 0.019 CID_18654381 | CID_18654381 | |
| 0.403 | 0.009 | 0.65 | Alpha-N-acetylglucosaminidase inhibitor | 0.65 0.003 CID_18654381 | CID_18654381 | |
| 0.396 | 0.005 | 0.396 | Estrogen antagonist | |||
| 0.419 | 0.03 | 0.631 | Vasodilator, coronary | 0.631 0.006 CID_18654381 | CID_18654381 | |
| 0.392 | 0.004 | 0.392 | Estrogen receptor beta antagonist | |||
| 0.42 | 0.034 | 0.42 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.393 | 0.008 | 0.393 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.323 0.018 CID_18654381 | ||
| 0.4 | 0.02 | 0.4 | Pyruvate kinase inhibitor | |||
| 0.373 | 0.005 | 0.373 | Succinate dehydrogenase inhibitor | 0.205 0.045 CID_18654381 | ||
| 0.402 | 0.037 | 0.402 | Lipoxygenase inhibitor | |||
| 0.382 | 0.023 | 0.382 | Sodium/bile acid cotransporter inhibitor | 0.285 0.093 CID_18654381 | ||
| 0.362 | 0.004 | 0.362 | Nitric-oxide synthase stimulant | 0.361 0.004 CID_18654381 | ||
| 0.378 | 0.027 | 0.378 | Antimitotic | 0.159 0.113 CID_18654381 | ||
| 0.445 | 0.097 | 0.696 | Alpha-glucosidase inhibitor | 0.696 0.035 CID_18654381 | CID_18654381 | |
| 0.37 | 0.022 | 0.37 | RNA-directed DNA polymerase inhibitor | 0.287 0.034 CID_18654381 | ||
| 0.352 | 0.005 | 0.352 | Histidine decarboxylase inhibitor | |||
| 0.373 | 0.026 | 0.373 | Sigma receptor agonist | |||
| 0.381 | 0.041 | 0.381 | Aryl hydrocarbon receptor agonist | |||
| 0.339 | 0.005 | 0.339 | Carbonic anhydrase XV inhibitor | |||
| 0.34 | 0.014 | 0.433 | Lipid peroxidase inhibitor | 0.433 0.008 CID_18654381 | CID_18654381 | |
| 0.413 | 0.09 | 0.413 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.325 | 0.004 | 0.325 | GABA C receptor rho-2 antagonist | |||
| 0.328 | 0.009 | 0.328 | NADPH oxidase inhibitor | 0.257 0.019 CID_18654381 | ||
| 0.355 | 0.036 | 0.768 | Hypoglycemic | 0.768 0.004 CID_18654381 | CID_18654381 | |
| 0.327 | 0.008 | 0.327 | GABA C receptor agonist | 0.094 0.073 CID_18654381 | ||
| 0.328 | 0.009 | 0.328 | Aldehyde dehydrogenase inhibitor | 0.285 0.013 CID_18654381 | ||
| 0.342 | 0.028 | 0.497 | Cyclic AMP phosphodiesterase inhibitor | 0.497 0.007 CID_18654381 | CID_18654381 | |
| 0.318 | 0.004 | 0.318 | Macrophage migration inhibitory factor inhibitor | |||
| 0.312 | 0.005 | 0.312 | Estrogen agonist | 0.087 0.021 CID_18654381 | ||
| 0.321 | 0.013 | 0.326 | Neurotrophic factor enhancer | 0.326 0.012 CID_18654381 | CID_18654381 | |
| 0.347 | 0.04 | 0.444 | Antiamyloidogenic | 0.444 0.022 CID_18654381 | CID_18654381 | |
| 0.306 | 0.005 | 0.306 | Carbonic anhydrase III inhibitor | 0.18 0.02 CID_18654381 | ||
| 0.316 | 0.021 | 0.428 | DNA methyltransferase I inhibitor | 0.428 0.007 CID_18654381 | CID_18654381 | |
| 0.299 | 0.005 | 0.299 | Beta tubulin antagonist | |||
| 0.308 | 0.017 | 0.598 | Monophenol monooxygenase inhibitor | 0.598 0.005 CID_18654381 | CID_18654381 | |
| 0.305 | 0.017 | 0.305 | Tumour necrosis factor antagonist | |||
| 0.329 | 0.043 | 0.329 | Insulysin inhibitor | |||
| 0.289 | 0.004 | 0.289 | Alpha tubulin antagonist | |||
| 0.32 | 0.037 | 0.482 | DNA synthesis inhibitor | 0.482 0.015 CID_18654381 | CID_18654381 | |
| 0.295 | 0.013 | 0.295 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.308 | 0.026 | 0.446 | DNA methylase inhibitor | 0.446 0.008 CID_18654381 | CID_18654381 | |
| 0.307 | 0.025 | 0.307 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.286 | 0.004 | 0.286 | Creatine kinase inhibitor | |||
| 0.285 | 0.004 | 0.285 | CF transmembrane conductance regulator agonist | 0.211 0.016 CID_18654381 | ||
| 0.339 | 0.061 | 0.586 | Apoptosis antagonist | 0.586 0.011 CID_18654381 | CID_18654381 | |
| 0.298 | 0.02 | 0.473 | Interferon gamma antagonist | 0.473 0.007 CID_18654381 | CID_18654381 | |
| 0.321 | 0.044 | 0.321 | Transcription factor STAT3 inhibitor | 0.176 0.17 CID_18654381 | ||
| 0.283 | 0.008 | 0.283 | Breast cancer-resistant protein inhibitor | |||
| 0.289 | 0.018 | 0.467 | Protein kinase stimulant | 0.467 0.005 CID_18654381 | CID_18654381 | |
| 0.316 | 0.047 | 0.316 | Transcription factor STAT inhibitor | |||
| 0.271 | 0.004 | 0.271 | Keratolytic | |||
| 0.309 | 0.044 | 0.466 | Interleukin agonist | 0.466 0.011 CID_18654381 | CID_18654381 | |
| 0.316 | 0.051 | 0.35 | DNA damaging | 0.35 0.041 CID_18654381 | CID_18654381 | |
| 0.274 | 0.01 | 0.274 | Interleukin 4 antagonist | 0.186 0.027 CID_18654381 | ||
| 0.304 | 0.04 | 0.557 | Nitric oxide antagonist | 0.557 0.012 CID_18654381 | CID_18654381 | |
| 0.272 | 0.008 | 0.288 | Mannose-6-phosphate isomerase inhibitor | 0.288 0.006 CID_18654381 | CID_18654381 | |
| 0.274 | 0.012 | 0.45 | UDP-glucose 4-epimerase inhibitor | 0.45 0.004 CID_18654381 | CID_18654381 | |
| 0.274 | 0.013 | 0.274 | 5-Lipoxygenase inhibitor | |||
| 0.306 | 0.051 | 0.566 | Tumour necrosis factor alpha release inhibitor | 0.566 0.009 CID_18654381 | CID_18654381 | |
| 0.274 | 0.021 | 0.274 | Phospholipase C inhibitor | 0.214 0.036 CID_18654381 | ||
| 0.316 | 0.064 | 0.424 | Spasmolytic | 0.424 0.036 CID_18654381 | CID_18654381 | |
| 0.255 | 0.008 | 0.255 | Carbonic anhydrase VI inhibitor | 0.109 0.034 CID_18654381 | ||
| 0.268 | 0.022 | 0.366 | Topoisomerase II inhibitor | 0.366 0.012 CID_18654381 | CID_18654381 | |
| 0.254 | 0.008 | 0.477 | NADH dehydrogenase inhibitor | 0.477 0.003 CID_18654381 | CID_18654381 | |
| 0.254 | 0.008 | 0.258 | Carbonic anhydrase XIII inhibitor | 0.258 0.008 CID_18654381 | CID_18654381 | |
| 0.254 | 0.009 | 0.254 | Toll-Like receptor 2 antagonist | 0.121 0.076 CID_18654381 | ||
| 0.256 | 0.012 | 0.617 | Expectorant | 0.617 0.003 CID_18654381 | CID_18654381 | |
| 0.26 | 0.018 | 0.26 | Heat shock protein 90 antagonist | |||
| 0.294 | 0.052 | 0.294 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.314 | 0.073 | 0.314 | Streptokinase A inhibitor | |||
| 0.248 | 0.01 | 0.347 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.347 0.005 CID_18654381 | CID_18654381 | |
| 0.253 | 0.017 | 0.253 | Cholesterol synthesis inhibitor | 0.179 0.033 CID_18654381 | ||
| 0.249 | 0.014 | 0.405 | ATPase inhibitor | 0.405 0.004 CID_18654381 | CID_18654381 | |
| 0.258 | 0.024 | 0.258 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.257 | 0.024 | 0.257 | Heat shock protein 90 alpha antagonist | |||
| 0.239 | 0.007 | 0.25 | Mucolytic | 0.25 0.006 CID_18654381 | CID_18654381 | |
| 0.268 | 0.036 | 0.538 | Non-steroidal antiinflammatory agent | 0.538 0.005 CID_18654381 | CID_18654381 | |
| 0.25 | 0.021 | 0.25 | Neurotensin receptor agonist | |||
| 0.283 | 0.056 | 0.853 | Angiogenesis stimulant | 0.853 0.003 CID_18654381 | CID_18654381 | |
| 0.231 | 0.004 | 0.231 | DOPA decarboxylase inhibitor | |||
| 0.336 | 0.11 | 0.662 | Antibacterial | 0.662 0.012 CID_18654381 | CID_18654381 | |
| 0.262 | 0.037 | 0.262 | Dual specificity phosphatase 3 inhibitor | |||
| 0.232 | 0.008 | 0.232 | GABA C receptor antagonist | |||
| 0.267 | 0.044 | 0.267 | ErbB-1 antagonist | |||
| 0.234 | 0.011 | 0.607 | Cyclooxygenase 3 inhibitor | 0.607 0.002 CID_18654381 | CID_18654381 | |
| 0.241 | 0.019 | 0.414 | Hexokinase inhibitor | 0.414 0.004 CID_18654381 | CID_18654381 | |
| 0.259 | 0.039 | 0.259 | P-glycoprotein inhibitor | 0.221 0.052 CID_18654381 | ||
| 0.231 | 0.011 | 0.231 | Arachidonic acid antagonist | 0.184 0.049 CID_18654381 | ||
| 0.272 | 0.054 | 0.272 | Interleukin antagonist | |||
| 0.253 | 0.036 | 0.253 | I kappa B kinase epsilon inhibitor | |||
| 0.269 | 0.052 | 0.277 | Psychostimulant | 0.277 0.049 CID_18654381 | CID_18654381 | |
| 0.303 | 0.086 | 0.727 | Antithrombotic | 0.727 0.007 CID_18654381 | CID_18654381 | |
| 0.226 | 0.009 | 0.226 | Porphobilinogen synthase inhibitor | |||
| 0.239 | 0.022 | 0.245 | Alkaline phosphatase inhibitor | 0.245 0.021 CID_18654381 | CID_18654381 | |
| 0.223 | 0.008 | 0.223 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.22 | 0.007 | 0.22 | Adenylate cyclase stimulant | 0.159 0.048 CID_18654381 | ||
| 0.218 | 0.006 | 0.218 | GABA C receptor rho-1 antagonist | |||
| 0.218 | 0.006 | 0.218 | Prolactin inhibitor | |||
| 0.246 | 0.037 | 0.246 | Insulin sensitizer | 0.24 0.04 CID_18654381 | ||
| 0.271 | 0.063 | 0.271 | Dyrk kinase inhibitor | |||
| 0.268 | 0.06 | 0.439 | Vasodilator | 0.439 0.018 CID_18654381 | CID_18654381 | |
| 0.242 | 0.036 | 0.242 | Amyloid beta precursor protein antagonist | |||
| 0.218 | 0.013 | 0.274 | Topoisomerase II alpha inhibitor | 0.274 0.009 CID_18654381 | CID_18654381 | |
| 0.209 | 0.004 | 0.23 | Glutamate release inhibitor | 0.23 0.004 CID_18654381 | CID_18654381 | |
| 0.215 | 0.01 | 0.314 | Photosensitizer | 0.314 0.004 CID_18654381 | CID_18654381 | |
| 0.234 | 0.03 | 0.397 | NOS3 expression enhancer | 0.397 0.008 CID_18654381 | CID_18654381 | |
| 0.246 | 0.044 | 0.599 | Hepatoprotectant | 0.599 0.005 CID_18654381 | CID_18654381 | |
| 0.206 | 0.005 | 0.215 | Heat shock protein 70 antagonist | 0.215 0.005 CID_18654381 | CID_18654381 | |
| 0.221 | 0.021 | 0.221 | Chelator | |||
| 0.202 | 0.003 | 0.202 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.208 | 0.01 | 0.208 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.215 | 0.017 | 0.314 | Xanthine oxidase inhibitor | 0.314 0.007 CID_18654381 | CID_18654381 | |
| 0.231 | 0.035 | 0.231 | Histone acetyltransferase inhibitor | |||
| 0.218 | 0.022 | 0.327 | Topoisomerase I inhibitor | 0.327 0.009 CID_18654381 | CID_18654381 | |
| 0.207 | 0.013 | 0.207 | 5 Hydroxytryptamine 3A agonist | |||
| 0.235 | 0.042 | 0.235 | Dual specificity phosphatase inhibitor | |||
| 0.226 | 0.034 | 0.226 | MAO inhibitor | |||
| 0.203 | 0.011 | 0.203 | Vanilloid 1 agonist | 0.182 0.017 CID_18654381 | ||
| 0.201 | 0.01 | 0.201 | TRPA1 agonist | 0.13 0.047 CID_18654381 | ||
| 0.196 | 0.007 | 0.196 | Glutamate decarboxylase inhibitor | |||
| 0.2 | 0.013 | 0.574 | Beta glucuronidase inhibitor | 0.574 0.003 CID_18654381 | CID_18654381 | |
| 0.211 | 0.024 | 0.211 | Catenin beta inhibitor | |||
| 0.292 | 0.106 | 0.292 | Prostaglandin dehydrogenase inhibitor | |||
| 0.19 | 0.005 | 0.19 | Estrogen receptor alpha agonist | |||
| 0.205 | 0.02 | 0.205 | Farnesoid X receptor antagonist | |||
| 0.214 | 0.029 | 0.214 | Cyclooxygenase 1 inhibitor | 0.12 0.08 CID_18654381 | ||
| 0.189 | 0.005 | 0.189 | Estrogen receptor beta agonist | |||
| 0.187 | 0.003 | 0.187 | Estrogen-related receptor beta agonist | |||
| 0.211 | 0.027 | 0.211 | MAO A inhibitor | |||
| 0.187 | 0.005 | 0.187 | Ca2+-transporting ATPase inhibitor | 0.181 0.006 CID_18654381 | ||
| 0.219 | 0.037 | 0.219 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.254 | 0.075 | 0.254 | Gastrin inhibitor | 0.218 0.121 CID_18654381 | ||
| 0.18 | 0.004 | 0.18 | D-Ala-D-Ala ligase inhibitor | |||
| 0.188 | 0.012 | 0.408 | Triose-phosphate isomerase inhibitor | 0.408 0.003 CID_18654381 | CID_18654381 | |
| 0.192 | 0.016 | 0.192 | Potassium channel (Ca-activated) activator | |||
| 0.181 | 0.008 | 0.181 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.192 | 0.02 | 0.192 | Bronchodilator | |||
| 0.229 | 0.057 | 0.503 | Platelet adhesion inhibitor | 0.503 0.005 CID_18654381 | CID_18654381 | |
| 0.291 | 0.12 | 0.291 | Calpain 2 inhibitor | |||
| 0.184 | 0.013 | 0.184 | Sphingomyelinase inhibitor | 0.168 0.018 CID_18654381 | ||
| 0.192 | 0.022 | 0.24 | Microtubule formation inhibitor | 0.24 0.011 CID_18654381 | CID_18654381 | |
| 0.171 | 0.004 | 0.171 | GABA B receptor agonist | |||
| 0.236 | 0.07 | 0.236 | Neuropeptide Y2 antagonist | |||
| 0.188 | 0.021 | 0.188 | Falcipain 3 inhibitor | |||
| 0.229 | 0.064 | 0.229 | MAP kinase kinase 2 inhibitor | |||
| 0.181 | 0.018 | 0.181 | Adenylate kinase inhibitor | 0.148 0.027 CID_18654381 | ||
| 0.182 | 0.023 | 0.202 | Beta amyloid protein antagonist | 0.202 0.016 CID_18654381 | CID_18654381 | |
| 0.204 | 0.046 | 0.204 | Cytidine deaminase inhibitor | |||
| 0.16 | 0.003 | 0.16 | Ryanodine receptor antagonist | 0.06 0.037 CID_18654381 | ||
| 0.168 | 0.013 | 0.204 | Toll-Like receptor 4 antagonist | 0.204 0.006 CID_18654381 | CID_18654381 | |
| 0.181 | 0.027 | 0.181 | Ferrochelatase inhibitor | |||
| 0.312 | 0.159 | 0.312 | DNA polymerase beta inhibitor | |||
| 0.168 | 0.015 | 0.29 | Phosphofructokinase-1 inhibitor | 0.29 0.006 CID_18654381 | CID_18654381 | |
| 0.156 | 0.005 | 0.156 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.176 | 0.027 | 0.176 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.181 | 0.032 | 0.358 | Alkylator | 0.358 0.009 CID_18654381 | CID_18654381 | |
| 0.16 | 0.012 | 0.17 | Acetylcholine release stimulant | 0.17 0.008 CID_18654381 | CID_18654381 | |
| 0.163 | 0.015 | 0.163 | Electron transport complex I inhibitor | |||
| 0.153 | 0.006 | 0.153 | Glycine receptor agonist | 0.131 0.01 CID_18654381 | ||
| 0.169 | 0.022 | 0.169 | Catalase inhibitor | |||
| 0.168 | 0.022 | 0.168 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.154 | 0.01 | 0.154 | Myeloperoxidase inhibitor | |||
| 0.243 | 0.099 | 0.529 | Immunostimulant | 0.529 0.025 CID_18654381 | CID_18654381 | |
| 0.161 | 0.018 | 0.161 | Alcohol dehydrogenase inhibitor | 0.131 0.028 CID_18654381 | ||
| 0.175 | 0.031 | 0.175 | Nav1.6 sodium channel blocker | |||
| 0.151 | 0.008 | 0.151 | GABA aminotransferase inhibitor | 0.14 0.01 CID_18654381 | ||
| 0.155 | 0.013 | 0.155 | Carbonic anhydrase V inhibitor | |||
| 0.16 | 0.018 | 0.16 | Urease inhibitor | |||
| 0.172 | 0.03 | 0.172 | MAO B inhibitor | |||
| 0.163 | 0.021 | 0.345 | DNA repair enzyme inhibitor | 0.345 0.004 CID_18654381 | CID_18654381 | |
| 0.18 | 0.04 | 0.376 | Cell wall synthesis inhibitor | 0.376 0.007 CID_18654381 | CID_18654381 | |
| 0.156 | 0.015 | 0.156 | Anabolic | 0.094 0.072 CID_18654381 | ||
| 0.3 | 0.161 | 0.3 | DNA directed DNA polymerase inhibitor | |||
| 0.142 | 0.003 | 0.142 | Glutamate (mGluR7) antagonist | 0.063 0.057 CID_18654381 | ||
| 0.181 | 0.041 | 0.181 | Bone formation stimulant | 0.133 0.074 CID_18654381 | ||
| 0.163 | 0.024 | 0.163 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.189 | 0.051 | 0.189 | Protein-tyrosine phosphatase inhibitor | 0.175 0.059 CID_18654381 | ||
| 0.187 | 0.05 | 0.187 | Phospholipase A2 inhibitor | 0.154 0.07 CID_18654381 | ||
| 0.142 | 0.004 | 0.142 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.173 | 0.036 | 0.173 | Neuropeptide Y1 antagonist | |||
| 0.144 | 0.008 | 0.144 | Purinergic P2X1 antagonist | 0.08 0.025 CID_18654381 | ||
| 0.147 | 0.013 | 0.152 | Interleukin 12 antagonist | 0.152 0.012 CID_18654381 | CID_18654381 | |
| 0.155 | 0.025 | 0.454 | AMP-activated protein kinase stimulant | 0.454 0.004 CID_18654381 | CID_18654381 | |
| 0.142 | 0.013 | 0.142 | Estrogen receptor alpha antagonist | |||
| 0.155 | 0.026 | 0.155 | Antineoplastic alkaloid | |||
| 0.157 | 0.028 | 0.157 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.157 | 0.028 | 0.157 | Protein kinase C gamma inhibitor | |||
| 0.222 | 0.093 | 0.222 | Calpain inhibitor | |||
| 0.212 | 0.085 | 0.446 | Peptidyltransferase inhibitor | 0.446 0.005 CID_18654381 | CID_18654381 | |
| 0.14 | 0.013 | 0.14 | Carbonic anhydrase VA inhibitor | |||
| 0.163 | 0.037 | 0.163 | Antibacterial (Helicobacter pylori) | |||
| 0.134 | 0.007 | 0.134 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.17 | 0.044 | 0.17 | Acetylcholinesterase inhibitor | |||
| 0.164 | 0.04 | 0.164 | MAP kinase kinase 4 inhibitor | |||
| 0.162 | 0.038 | 0.162 | Cathepsin H inhibitor | |||
| 0.129 | 0.005 | 0.129 | Heat shock protein 90 beta antagonist | |||
| 0.16 | 0.038 | 0.16 | Pregnane X receptor agonist | |||
| 0.175 | 0.053 | 0.175 | Cyclooxygenase inhibitor | 0.114 0.106 CID_18654381 | ||
| 0.136 | 0.015 | 0.136 | Purinergic P2X2 antagonist | |||
| 0.159 | 0.039 | 0.159 | Adenylate cyclase inhibitor | 0.094 0.09 CID_18654381 | ||
| 0.13 | 0.011 | 0.13 | Carbonic anhydrase VB inhibitor | |||
| 0.136 | 0.018 | 0.136 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.155 | 0.037 | 0.155 | Interleukin 1b antagonist | 0.109 0.071 CID_18654381 | ||
| 0.126 | 0.009 | 0.126 | Beta 3 adrenoreceptor antagonist | |||
| 0.136 | 0.018 | 0.136 | Glutamate (mGluR7) agonist | |||
| 0.136 | 0.019 | 0.136 | Adrenaline agonist | |||
| 0.119 | 0.004 | 0.119 | Dopamine D5 agonist | |||
| 0.138 | 0.023 | 0.138 | Protein kinase C zeta inhibitor | |||
| 0.137 | 0.022 | 0.137 | Phosphodiesterase 4D inhibitor | |||
| 0.128 | 0.014 | 0.128 | Bile acid receptor antagonist | 0.093 0.066 CID_18654381 | ||
| 0.124 | 0.011 | 0.124 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.119 0.012 CID_18654381 | ||
| 0.315 | 0.202 | 0.828 | Antiinflammatory | 0.828 0.012 CID_18654381 | CID_18654381 | |
| 0.242 | 0.129 | 0.242 | Thyroid hormone antagonist | |||
| 0.15 | 0.038 | 0.15 | Aminopeptidase B inhibitor | |||
| 0.129 | 0.017 | 0.129 | HIV-1 integrase (3'-Processing) inhibitor | 0.065 0.043 CID_18654381 | ||
| 0.147 | 0.036 | 0.147 | Interleukin 8 antagonist | |||
| 0.141 | 0.03 | 0.141 | Transcription factor STAT6 inhibitor | |||
| 0.116 | 0.005 | 0.116 | MAP kinase kinase 7 inhibitor | |||
| 0.124 | 0.015 | 0.124 | Carbamoyl phosphate synthetase inhibitor | 0.075 0.031 CID_18654381 | ||
| 0.278 | 0.168 | 0.278 | Transcription factor inhibitor | |||
| 0.178 | 0.068 | 0.178 | Mcl-1 antagonist | |||
| 0.125 | 0.016 | 0.125 | Vanilloid agonist | |||
| 0.12 | 0.011 | 0.12 | Xanthine dehydrogenase inhibitor | 0.056 0.041 CID_18654381 | ||
| 0.169 | 0.062 | 0.169 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.113 | 0.006 | 0.113 | Potassium channel Kv1.3 blocker | |||
| 0.152 | 0.045 | 0.175 | Protein-tyrosine phosphatase 1B inhibitor | 0.175 0.036 CID_18654381 | CID_18654381 | |
| 0.162 | 0.056 | 0.162 | Toll-Like receptor 9 antagonist | |||
| 0.17 | 0.064 | 0.29 | Interleukin 6 antagonist | 0.29 0.016 CID_18654381 | CID_18654381 | |
| 0.153 | 0.047 | 0.178 | DNA polymerase I inhibitor | 0.178 0.036 CID_18654381 | CID_18654381 | |
| 0.153 | 0.048 | 0.153 | Anesthetic local | |||
| 0.125 | 0.021 | 0.185 | Phosphodiesterase 6D inhibitor | 0.185 0.005 CID_18654381 | CID_18654381 | |
| 0.109 | 0.005 | 0.109 | Calcium channel P-type blocker | |||
| 0.129 | 0.026 | 0.163 | Thioredoxin inhibitor | 0.163 0.013 CID_18654381 | CID_18654381 | |
| 0.107 | 0.005 | 0.107 | Transcription factor RelA inhibitor | |||
| 0.242 | 0.14 | 0.242 | Thioredoxin glutathione reductase inhibitor | |||
| 0.136 | 0.034 | 0.149 | Multidrug resistance-associated protein 1 inhibitor | 0.149 0.026 CID_18654381 | CID_18654381 | |
| 0.12 | 0.018 | 0.12 | mTOR complex 2 inhibitor | |||
| 0.118 | 0.017 | 0.118 | Potassium channel large-conductance Ca-activated activator | |||
| 0.11 | 0.009 | 0.177 | Carbonic anhydrase XIV inhibitor | 0.177 0.005 CID_18654381 | CID_18654381 | |
| 0.136 | 0.036 | 0.36 | Mediator release inhibitor | 0.36 0.005 CID_18654381 | CID_18654381 | |
| 0.138 | 0.038 | 0.138 | Caspase 3 inhibitor | |||
| 0.112 | 0.012 | 0.112 | Beta adrenoreceptor antagonist | |||
| 0.248 | 0.149 | 0.555 | Immunosuppressant | 0.555 0.02 CID_18654381 | CID_18654381 | |
| 0.129 | 0.03 | 0.129 | Calcium antagonist | |||
| 0.12 | 0.023 | 0.12 | Glutamate dehydrogenase inhibitor | 0.089 0.037 CID_18654381 | ||
| 0.11 | 0.013 | 0.11 | CC chemokine 5 receptor agonist | |||
| 0.127 | 0.03 | 0.127 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.127 | 0.03 | 0.127 | Phosphodiesterase IV inhibitor | |||
| 0.115 | 0.019 | 0.115 | Leukotriene synthesis inhibitor | |||
| 0.117 | 0.022 | 0.147 | ATPase (Vacuolar H+) inhibitor | 0.147 0.008 CID_18654381 | CID_18654381 | |
| 0.102 | 0.007 | 0.102 | Cyclin D1 inhibitor | |||
| 0.227 | 0.133 | 0.227 | Thyroid hormone beta antagonist | |||
| 0.122 | 0.028 | 0.122 | Histamine N-methyltransferase inhibitor | |||
| 0.097 | 0.005 | 0.097 | Dihydropteroate synthase inhibitor | |||
| 0.097 | 0.004 | 0.097 | Adenylate cyclase 1 inhibitor | |||
| 0.119 | 0.026 | 0.119 | Ornithine decarboxylase inhibitor | 0.097 0.047 CID_18654381 | ||
| 0.105 | 0.013 | 0.105 | 5 Hydroxytryptamine 2A agonist | |||
| 0.125 | 0.033 | 0.125 | Electrolyte absorption antagonist | |||
| 0.124 | 0.031 | 0.124 | Androgen antagonist | |||
| 0.111 | 0.019 | 0.111 | HIV-1 integrase inhibitor | |||
| 0.116 | 0.025 | 0.116 | Glutathione S-transferase inhibitor | |||
| 0.128 | 0.038 | 0.128 | Gastric antisecretory | |||
| 0.286 | 0.196 | 0.286 | MAP kinase 1 inhibitor | |||
| 0.099 | 0.01 | 0.099 | Exportin-1 inhibitor | |||
| 0.108 | 0.02 | 0.108 | HIV-1 integrase (Strand Transfer) inhibitor | 0.06 0.042 CID_18654381 | ||
| 0.109 | 0.02 | 0.109 | Caspase 7 inhibitor | |||
| 0.092 | 0.004 | 0.092 | Pregnane X receptor antagonist | |||
| 0.147 | 0.06 | 0.147 | Interleukin 1 antagonist | |||
| 0.096 | 0.01 | 0.096 | Topoisomerase II beta inhibitor | 0.067 0.018 CID_18654381 | ||
| 0.093 | 0.007 | 0.135 | Glucose-6-phosphate translocase inhibitor | 0.135 0.004 CID_18654381 | CID_18654381 | |
| 0.108 | 0.023 | 0.108 | Dopamine D1 antagonist | |||
| 0.089 | 0.004 | 0.089 | Dopamine beta hydroxylase inhibitor | |||
| 0.088 | 0.003 | 0.088 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.108 | 0.024 | 0.128 | Na+ K+ transporting ATPase inhibitor | 0.128 0.012 CID_18654381 | CID_18654381 | |
| 0.098 | 0.015 | 0.113 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.113 0.012 CID_18654381 | CID_18654381 | |
| 0.113 | 0.029 | 0.113 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.101 | 0.018 | 0.101 | Biliverdin reductase inhibitor | 0.075 0.029 CID_18654381 | ||
| 0.099 | 0.016 | 0.099 | Potassium channel (ATP-sensitive) blocker | |||
| 0.101 | 0.019 | 0.101 | Acetylcholine M5 receptor agonist | |||
| 0.092 | 0.01 | 0.092 | Aconitate hydratase inhibitor | |||
| 0.175 | 0.093 | 0.175 | Focal adhesion kinase 2 inhibitor | |||
| 0.086 | 0.005 | 0.086 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.161 | 0.079 | 0.161 | Growth hormone agonist | |||
| 0.093 | 0.012 | 0.093 | Beta 1 adrenoreceptor antagonist | |||
| 0.131 | 0.05 | 0.131 | Alpha 2b adrenoreceptor antagonist | |||
| 0.15 | 0.07 | 0.15 | CDC-like kinase 1 inhibitor | |||
| 0.162 | 0.081 | 0.162 | Death-associated protein kinase 2 inhibitor | |||
| 0.094 | 0.013 | 0.094 | Glutamate (mGluR6) antagonist | 0.065 0.051 CID_18654381 | ||
| 0.105 | 0.025 | 0.105 | Thioredoxin reductase inhibitor | |||
| 0.087 | 0.007 | 0.131 | Glucose-6-phosphate isomerase inhibitor | 0.131 0.003 CID_18654381 | CID_18654381 | |
| 0.087 | 0.008 | 0.087 | Squalene epoxidase inhibitor | |||
| 0.096 | 0.017 | 0.096 | Acyl-CoA dehydrogenase inhibitor | 0.051 0.041 CID_18654381 | ||
| 0.097 | 0.018 | 0.128 | Aldose reductase inhibitor | 0.128 0.013 CID_18654381 | CID_18654381 | |
| 0.088 | 0.01 | 0.088 | 5 Hydroxytryptamine 7 agonist | |||
| 0.108 | 0.029 | 0.108 | Opioid kappa receptor antagonist | |||
| 0.116 | 0.038 | 0.116 | Opioid antagonist | |||
| 0.089 | 0.011 | 0.089 | Sphingosine kinase 2 inhibitor | |||
| 0.087 | 0.009 | 0.27 | Alpha-mannosidase inhibitor | 0.27 0.002 CID_18654381 | CID_18654381 | |
| 0.148 | 0.071 | 0.465 | Hemostatic | 0.465 0.005 CID_18654381 | CID_18654381 | |
| 0.14 | 0.063 | 0.14 | Toll-Like receptor antagonist | |||
| 0.104 | 0.029 | 0.156 | Glycine receptor antagonist | 0.156 0.006 CID_18654381 | CID_18654381 | |
| 0.098 | 0.022 | 0.098 | Aromatase inhibitor | |||
| 0.115 | 0.04 | 0.115 | MAP kinase kinase 1 inhibitor | |||
| 0.097 | 0.022 | 0.107 | Phosphodiesterase VI inhibitor | 0.107 0.016 CID_18654381 | CID_18654381 | |
| 0.079 | 0.003 | 0.079 | Estrogen-related receptor beta antagonist | |||
| 0.092 | 0.017 | 0.092 | Aryl hydrocarbon receptor antagonist | |||
| 0.079 | 0.005 | 0.079 | Alpha 1d adrenoreceptor agonist | |||
| 0.099 | 0.025 | 0.099 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.092 | 0.018 | 0.092 | Androgen agonist | |||
| 0.12 | 0.049 | 0.12 | Alpha 2c adrenoreceptor antagonist | |||
| 0.147 | 0.077 | 0.147 | Acetylcholine M1 receptor antagonist | |||
| 0.104 | 0.034 | 0.104 | CYP2A6 inhibitor | |||
| 0.128 | 0.059 | 0.128 | Proteasome inhibitor | |||
| 0.098 | 0.029 | 0.098 | Aminopeptidase I inhibitor | |||
| 0.106 | 0.038 | 0.106 | Phosphodiesterase I inhibitor | |||
| 0.222 | 0.154 | 0.471 | Interleukin 2 agonist | 0.471 0.012 CID_18654381 | CID_18654381 | |
| 0.09 | 0.023 | 0.09 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.079 | 0.012 | 0.079 | Beta 2 adrenoreceptor antagonist | |||
| 0.11 | 0.044 | 0.177 | Uric acid excretion stimulant | 0.177 0.017 CID_18654381 | CID_18654381 | |
| 0.077 | 0.01 | 0.077 | Vanilloid 2 antagonist | |||
| 0.07 | 0.004 | 0.07 | Vanilloid 3 antagonist | |||
| 0.076 | 0.01 | 0.262 | Mannosidase inhibitor | 0.262 0.002 CID_18654381 | CID_18654381 | |
| 0.074 | 0.009 | 0.074 | Estrogen-related receptor alpha antagonist | |||
| 0.083 | 0.017 | 0.083 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.069 | 0.005 | 0.074 | Guanylate cyclase inhibitor | 0.074 0.004 CID_18654381 | CID_18654381 | |
| 0.076 | 0.012 | 0.076 | Beta 2 adrenoreceptor agonist | |||
| 0.095 | 0.031 | 0.095 | Opioid delta receptor antagonist | |||
| 0.098 | 0.034 | 0.098 | Cathepsin G inhibitor | |||
| 0.085 | 0.023 | 0.085 | Maillard reaction inhibitor | |||
| 0.072 | 0.009 | 0.072 | Phosphoglycerate kinase inhibitor | 0.033 0.027 CID_18654381 | ||
| 0.133 | 0.07 | 0.133 | Nav1.2 sodium channel blocker | |||
| 0.076 | 0.013 | 0.076 | Dihydroorotate oxidase inhibitor | |||
| 0.131 | 0.068 | 0.131 | M17 leucyl aminopeptidase inhibitor | |||
| 0.085 | 0.023 | 0.085 | Argininosuccinate synthase inhibitor | 0.063 0.035 CID_18654381 | ||
| 0.139 | 0.077 | 0.139 | Activin receptor-like kinase 2 inhibitor | |||
| 0.072 | 0.011 | 0.072 | Alpha 1L adrenoreceptor antagonist | |||
| 0.066 | 0.005 | 0.066 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.101 | 0.04 | 0.101 | Interleukin 5 antagonist | 0.095 0.047 CID_18654381 | ||
| 0.075 | 0.014 | 0.075 | Carbonic anhydrase VII inhibitor | |||
| 0.135 | 0.075 | 0.135 | Cytokine production inhibitor | |||
| 0.07 | 0.011 | 0.07 | Immunoglobulin Fc receptor antagonist | |||
| 0.1 | 0.04 | 0.1 | Bromodomain-containing protein 2 inhibitor | |||
| 0.093 | 0.036 | 0.093 | Metalloproteinase-9 inhibitor | |||
| 0.086 | 0.028 | 0.086 | Leukotriene antagonist | 0.078 0.033 CID_18654381 | ||
| 0.141 | 0.084 | 0.386 | Insulin secretagoues | 0.386 0.007 CID_18654381 | CID_18654381 | |
| 0.143 | 0.086 | 0.143 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.062 | 0.006 | 0.062 | Kainate receptor agonist | |||
| 0.062 | 0.006 | 0.062 | Glutamate (mGluR8) agonist | |||
| 0.07 | 0.014 | 0.07 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.137 | 0.081 | 0.137 | MAP3K9 inhibitor | |||
| 0.09 | 0.035 | 0.09 | Opioid mu receptor antagonist | |||
| 0.07 | 0.015 | 0.085 | Adenine nucleotide translocase inhibitor | 0.085 0.007 CID_18654381 | CID_18654381 | |
| 0.064 | 0.009 | 0.064 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.071 | 0.017 | 0.071 | Epithelial sodium channel blocker | |||
| 0.07 | 0.016 | 0.07 | NMDA receptor subunit 3B antagonist | |||
| 0.127 | 0.073 | 0.127 | Cyclooxygenase 2 inhibitor | |||
| 0.079 | 0.026 | 0.079 | NMDA 2C receptor antagonist | |||
| 0.072 | 0.019 | 0.112 | Leukotriene B4 antagonist | 0.112 0.008 CID_18654381 | CID_18654381 | |
| 0.058 | 0.005 | 0.141 | Sodium/glucose cotransporter 2 inhibitor | 0.141 0.002 CID_18654381 | CID_18654381 | |
| 0.211 | 0.157 | 0.393 | Angiogenesis inhibitor | 0.393 0.055 CID_18654381 | CID_18654381 | |
| 0.067 | 0.014 | 0.288 | Heparanase inhibitor | 0.288 0.002 CID_18654381 | CID_18654381 | |
| 0.058 | 0.006 | 0.071 | Uridine phosphorylase inhibitor | 0.071 0.004 CID_18654381 | CID_18654381 | |
| 0.138 | 0.086 | 0.138 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.094 | 0.042 | 0.094 | Inducible nitric-oxide synthase inhibitor | |||
| 0.054 | 0.003 | 0.054 | Estrogen-related receptor gamma antagonist | |||
| 0.065 | 0.014 | 0.07 | Factor III inhibitor | 0.07 0.011 CID_18654381 | CID_18654381 | |
| 0.061 | 0.01 | 0.061 | Fumarate hydratase inhibitor | 0.047 0.015 CID_18654381 | ||
| 0.09 | 0.039 | 0.119 | Interferon agonist | 0.119 0.018 CID_18654381 | CID_18654381 | |
| 0.056 | 0.006 | 0.056 | Melatonin receptor 1A agonist | |||
| 0.067 | 0.017 | 0.067 | CD45 antagonist | |||
| 0.058 | 0.008 | 0.058 | Melatonin 2 agonist | 0.032 0.023 CID_18654381 | ||
| 0.072 | 0.023 | 0.072 | Sphingosine kinase inhibitor | |||
| 0.086 | 0.038 | 0.133 | Histone deacetylase SIRT1 stimulant | 0.133 0.013 CID_18654381 | CID_18654381 | |
| 0.086 | 0.038 | 0.133 | Histone deacetylase stimulant | 0.133 0.013 CID_18654381 | CID_18654381 | |
| 0.087 | 0.039 | 0.087 | NMDA 2 receptor antagonist | |||
| 0.057 | 0.009 | 0.057 | Glutamate (mGluR3) antagonist | |||
| 0.078 | 0.03 | 0.078 | NMDA receptor glycine site agonist | |||
| 0.052 | 0.004 | 0.052 | Glutamate (mGluR3) agonist | |||
| 0.073 | 0.026 | 0.073 | Phosphodiesterase 1C inhibitor | |||
| 0.128 | 0.08 | 0.162 | CC chemokine 6 receptor antagonist | 0.162 0.011 CID_18654381 | CID_18654381 | |
| 0.112 | 0.066 | 0.112 | Nav1.5 sodium channel blocker | |||
| 0.059 | 0.013 | 0.059 | Liver X receptor alpha agonist | |||
| 0.078 | 0.033 | 0.078 | Protein kinase C beta inhibitor | |||
| 0.072 | 0.028 | 0.072 | Phosphodiesterase 1B inhibitor | |||
| 0.064 | 0.021 | 0.064 | Leukotriene C antagonist | |||
| 0.08 | 0.037 | 0.08 | Dopamine agonist | |||
| 0.08 | 0.037 | 0.08 | Amidase inhibitor | |||
| 0.057 | 0.016 | 0.057 | Geranyltranstransferase inhibitor | |||
| 0.079 | 0.037 | 0.079 | Phospholipase D inhibitor | |||
| 0.093 | 0.051 | 0.093 | NMDA receptor antagonist | |||
| 0.065 | 0.023 | 0.065 | Glycine transporter 2 inhibitor | |||
| 0.135 | 0.094 | 0.135 | MAP kinase 3 inhibitor | |||
| 0.082 | 0.041 | 0.082 | Adenosine A3 receptor antagonist | |||
| 0.143 | 0.103 | 0.143 | Antipruritic | |||
| 0.089 | 0.049 | 0.089 | Platelet growth factor antagonist | |||
| 0.058 | 0.018 | 0.058 | Oxytocin agonist | |||
| 0.049 | 0.009 | 0.049 | CF transmembrane conductance regulator antagonist | |||
| 0.044 | 0.004 | 0.044 | Hedgehog signaling activator | |||
| 0.058 | 0.018 | 0.058 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.116 | 0.078 | 0.116 | MAP kinase kinase inhibitor | |||
| 0.047 | 0.009 | 0.047 | ATP citrate lysase inhibitor | |||
| 0.075 | 0.037 | 0.075 | Fibroblast growth factor 2 antagonist | |||
| 0.06 | 0.022 | 0.06 | CXC chemokine 1 receptor antagonist | |||
| 0.044 | 0.006 | 0.155 | Sodium/glucose cotransporter inhibitor | 0.155 0.002 CID_18654381 | CID_18654381 | |
| 0.052 | 0.015 | 0.052 | Beta adrenoreceptor agonist | |||
| 0.082 | 0.045 | 0.082 | Analgesic, opioid | |||
| 0.076 | 0.039 | 0.076 | Phosphodiesterase III inhibitor | |||
| 0.077 | 0.04 | 0.077 | Secretase beta inhibitor | |||
| 0.083 | 0.047 | 0.083 | Alpha 2a adrenoreceptor antagonist | |||
| 0.051 | 0.015 | 0.051 | GABA uptake inhibitor | |||
| 0.088 | 0.052 | 0.293 | Antineoplastic antibiotic | 0.293 0.01 CID_18654381 | CID_18654381 | |
| 0.063 | 0.028 | 0.063 | Glucosylceramidase inhibitor | |||
| 0.054 | 0.019 | 0.054 | Purinergic P2X4 antagonist | |||
| 0.07 | 0.035 | 0.07 | 5 Hydroxytryptamine 3 agonist | |||
| 0.056 | 0.021 | 0.056 | Dopamine D5 antagonist | |||
| 0.071 | 0.037 | 0.071 | CDC25B inhibitor | |||
| 0.07 | 0.035 | 0.091 | Interferon inducer | 0.091 0.017 CID_18654381 | CID_18654381 | |
| 0.051 | 0.017 | 0.051 | Dihydrofolate reductase inhibitor | |||
| 0.039 | 0.005 | 0.039 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.088 | 0.054 | 0.203 | Transcription factor NF kappa B stimulant | 0.203 0.009 CID_18654381 | CID_18654381 | |
| 0.064 | 0.03 | 0.064 | Fatty acid synthase inhibitor | |||
| 0.075 | 0.041 | 0.075 | Alpha adrenoreceptor agonist | |||
| 0.049 | 0.015 | 0.049 | Heme oxygenase inhibitor | |||
| 0.057 | 0.024 | 0.057 | Adenosine deaminase inhibitor | 0.054 0.027 CID_18654381 | ||
| 0.075 | 0.042 | 0.075 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.045 | 0.012 | 0.045 | Free fatty acid receptor 1 antagonist | |||
| 0.078 | 0.045 | 0.078 | CDC25A inhibitor | |||
| 0.052 | 0.019 | 0.052 | NMDA receptor subunit 3A antagonist | |||
| 0.044 | 0.012 | 0.044 | Melatonin 1 agonist | |||
| 0.082 | 0.05 | 0.082 | Metalloproteinase-2 inhibitor | |||
| 0.065 | 0.033 | 0.065 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.089 | 0.057 | 0.089 | Alpha 2 adrenoreceptor antagonist | |||
| 0.051 | 0.019 | 0.051 | Glutamate (mGluR group III) antagonist | |||
| 0.069 | 0.038 | 0.069 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.057 | 0.025 | 0.057 | Opioid mu receptor agonist | |||
| 0.064 | 0.033 | 0.064 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.034 | 0.003 | 0.055 | Antibiotic Anthracycline-like | 0.055 0.001 CID_18654381 | CID_18654381 | |
| 0.049 | 0.018 | 0.049 | DNA gyrase subunit A inhibitor | |||
| 0.044 | 0.012 | 0.044 | Melatonin agonist | |||
| 0.113 | 0.082 | 0.113 | Nav1.3 sodium channel blocker | |||
| 0.07 | 0.039 | 0.07 | MDM2 inhibitor | |||
| 0.043 | 0.012 | 0.043 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.042 | 0.011 | 0.042 | Liver X receptor beta antagonist | |||
| 0.043 | 0.013 | 0.043 | Carnitine palmitoyltransferase inhibitor | |||
| 0.096 | 0.065 | 0.096 | Butyrylcholinesterase inhibitor | |||
| 0.037 | 0.007 | 0.037 | Thyroid hormone agonist | |||
| 0.054 | 0.024 | 0.054 | Cholesterol esterase inhibitor | |||
| 0.06 | 0.031 | 0.06 | Matrix metalloproteinase 1 inhibitor | |||
| 0.056 | 0.027 | 0.056 | Plasminogen activator inhibitor antagonist | |||
| 0.098 | 0.069 | 0.098 | Nav1.1 sodium channel blocker | |||
| 0.065 | 0.036 | 0.065 | Collagenase 3 inhibitor | |||
| 0.102 | 0.074 | 0.102 | GABA receptor agonist | |||
| 0.046 | 0.018 | 0.046 | Diamine oxidase inhibitor | |||
| 0.04 | 0.013 | 0.04 | Cholesterol ester transfer protein antagonist | |||
| 0.044 | 0.017 | 0.044 | Nicotinic acid receptor agonist | |||
| 0.066 | 0.039 | 0.066 | NMDA receptor agonist | |||
| 0.064 | 0.037 | 0.064 | Alpha 2 adrenoreceptor agonist | |||
| 0.052 | 0.025 | 0.052 | Dopamine D2 agonist | |||
| 0.031 | 0.005 | 0.075 | Ileal bile acid transport inhibitor | 0.075 0.003 CID_18654381 | CID_18654381 | |
| 0.036 | 0.01 | 0.036 | Purinergic P2Y15 antagonist | |||
| 0.05 | 0.024 | 0.05 | Glutamate (mGluR group III) agonist | |||
| 0.036 | 0.01 | 0.036 | Dopamine autoreceptor agonist | |||
| 0.033 | 0.007 | 0.033 | Prostaglandin F2 alpha agonist | |||
| 0.137 | 0.112 | 0.137 | LIM domain kinase 1 inhibitor | |||
| 0.039 | 0.014 | 0.039 | Catechol O-methyltransferase inhibitor | |||
| 0.05 | 0.025 | 0.05 | Phosphodiesterase 3B inhibitor | |||
| 0.047 | 0.023 | 0.047 | GABA B receptor antagonist | |||
| 0.058 | 0.033 | 0.058 | NMDA 2B receptor antagonist | |||
| 0.107 | 0.082 | 0.107 | Acetylcholine muscarinic antagonist | |||
| 0.029 | 0.005 | 0.029 | NMDA receptor phencyclidine site antagonist | |||
| 0.051 | 0.027 | 0.066 | Cytokine production stimulant | 0.066 0.009 CID_18654381 | CID_18654381 | |
| 0.057 | 0.033 | 0.057 | DNA helicase inhibitor | |||
| 0.071 | 0.047 | 0.071 | ZAP-70 protein tyrosine kinase inhibitor | |||
| 0.032 | 0.008 | 0.051 | Vanilloid 2 agonist | 0.051 0.003 CID_18654381 | CID_18654381 | |
| 0.028 | 0.004 | 0.028 | Estrogen-related receptor gamma agonist | |||
| 0.069 | 0.045 | 0.069 | Matrix metalloproteinase inhibitor | |||
| 0.048 | 0.025 | 0.048 | AICAR transformylase inhibitor | |||
| 0.074 | 0.051 | 0.074 | Potassium channel (Tandem pore domain) blocker | |||
| 0.038 | 0.015 | 0.038 | HCV NS5B polymerase inhibitor | |||
| 0.06 | 0.037 | 0.06 | Botulinum neurotoxin type A inhibitor | |||
| 0.06 | 0.037 | 0.06 | Alpha 1 adrenoreceptor agonist | |||
| 0.056 | 0.033 | 0.056 | NMDA 2A receptor antagonist | |||
| 0.037 | 0.014 | 0.037 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.045 | 0.022 | 0.045 | Plasmepsin II inhibitor | |||
| 0.062 | 0.04 | 0.062 | Heme oxygenase stimulant | |||
| 0.063 | 0.04 | 0.063 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.036 | 0.014 | 0.036 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.044 | 0.022 | 0.044 | Urate transporter 1 inhibitor | |||
| 0.05 | 0.028 | 0.05 | CC chemokine 4 receptor antagonist | |||
| 0.076 | 0.055 | 0.076 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.071 | 0.05 | 0.071 | Calcium channel L-type blocker | |||
| 0.19 | 0.169 | 0.19 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.087 | 0.067 | 0.087 | Polo-like kinase-1 inhibitor | |||
| 0.042 | 0.021 | 0.042 | 5 Hydroxytryptamine 2B agonist | |||
| 0.052 | 0.031 | 0.052 | Potassium channel (Inward rectifier) activator | |||
| 0.039 | 0.018 | 0.039 | Ceramide glucosyltransferase inhibitor | 0.039 0.019 CID_18654381 | ||
| 0.041 | 0.02 | 0.041 | Delayed rectifier potassium channel blocker | |||
| 0.045 | 0.025 | 0.045 | Nerve growth factor antagonist | |||
| 0.058 | 0.039 | 0.058 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.098 | 0.078 | 0.098 | Protein kinase (CK2) alpha inhibitor | |||
| 0.054 | 0.035 | 0.054 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.041 | 0.022 | 0.041 | Leukotriene C4 antagonist | |||
| 0.049 | 0.03 | 0.049 | Benzodiazepine antagonist | |||
| 0.024 | 0.005 | 0.024 | Nicotinic acid receptor 1 antagonist | |||
| 0.027 | 0.008 | 0.027 | Isoleucine-tRNA ligase inhibitor | 0.025 0.011 CID_18654381 | ||
| 0.033 | 0.014 | 0.033 | Thiazolidinedione | |||
| 0.049 | 0.031 | 0.049 | Potassium channel (ATP-sensitive) activator | |||
| 0.054 | 0.036 | 0.054 | Ornithine carbamoyltransferase inhibitor | |||
| 0.038 | 0.02 | 0.038 | RNA-directed RNA polymerase inhibitor | |||
| 0.077 | 0.06 | 0.077 | Phosphodiesterase 3A inhibitor | |||
| 0.065 | 0.049 | 0.065 | Phosphodiesterase 4B inhibitor | |||
| 0.063 | 0.047 | 0.063 | Neutrophil collagenase inhibitor | |||
| 0.059 | 0.042 | 0.059 | Acetylcholine M3 receptor antagonist | |||
| 0.03 | 0.013 | 0.03 | Nicotinic acid receptor 2 antagonist | |||
| 0.06 | 0.043 | 0.06 | TRPA1 antagonist | |||
| 0.05 | 0.034 | 0.05 | Bombesin 2 receptor antagonist | |||
| 0.028 | 0.012 | 0.028 | Complement factor 1s inhibitor | |||
| 0.051 | 0.036 | 0.051 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.035 | 0.019 | 0.035 | Protein kinase (CK2) beta inhibitor | |||
| 0.027 | 0.011 | 0.027 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.052 | 0.036 | 0.052 | 5 Hydroxytryptamine 2 agonist | |||
| 0.06 | 0.045 | 0.06 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.049 | 0.034 | 0.049 | Metalloproteinase-3 inhibitor | |||
| 0.039 | 0.024 | 0.039 | Farnesoid X receptor agonist | |||
| 0.019 | 0.004 | 0.019 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.058 | 0.043 | 0.058 | Carbonic anhydrase stimulant | |||
| 0.026 | 0.011 | 0.026 | Glutamate (mGluR1a) agonist | |||
| 0.021 | 0.007 | 0.029 | Telomerase stimulant | 0.029 0.003 CID_18654381 | CID_18654381 | |
| 0.042 | 0.028 | 0.042 | Sphingosine kinase 1 inhibitor | |||
| 0.045 | 0.031 | 0.045 | Dihydroorotase inhibitor | |||
| 0.053 | 0.039 | 0.053 | Lysine-specific demethylase 1A inhibitor | |||
| 0.036 | 0.022 | 0.036 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.088 | 0.074 | 0.088 | Toll-Like receptor 3 antagonist | |||
| 0.026 | 0.013 | 0.026 | CYP24 inhibitor | |||
| 0.031 | 0.017 | 0.031 | Liver X receptor alpha antagonist | |||
| 0.05 | 0.037 | 0.05 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.04 | 0.027 | 0.04 | Dopamine D3 agonist | |||
| 0.069 | 0.056 | 0.069 | Lipase inhibitor | |||
| 0.051 | 0.038 | 0.051 | Opioid agonist | |||
| 0.035 | 0.022 | 0.035 | Tubulin agonist | |||
| 0.03 | 0.017 | 0.03 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.062 | 0.049 | 0.135 | Neuraminidase (influenza) inhibitor | 0.135 0.009 CID_18654381 | CID_18654381 | |
| 0.023 | 0.011 | 0.023 | Neuraminidase (Influenza B) inhibitor | |||
| 0.059 | 0.047 | 0.059 | Carbonic anhydrase inhibitor | 0.058 0.047 CID_18654381 | ||
| 0.038 | 0.026 | 0.038 | Retinoid X receptor antagonist | |||
| 0.025 | 0.013 | 0.025 | Beta 1 adrenoreceptor agonist | |||
| 0.034 | 0.022 | 0.034 | Liver X receptor beta agonist | |||
| 0.035 | 0.024 | 0.035 | Opioid delta receptor agonist | |||
| 0.122 | 0.112 | 0.122 | Thiol protease inhibitor | |||
| 0.046 | 0.036 | 0.046 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.085 | 0.075 | 0.085 | ABCA1 expression enhancer | |||
| 0.046 | 0.036 | 0.046 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.089 | 0.079 | 0.089 | Nitric-oxide synthase inhibitor | |||
| 0.019 | 0.01 | 0.019 | Alpha 2a adrenoreceptor agonist | |||
| 0.052 | 0.043 | 0.052 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.047 | 0.037 | 0.047 | Phosphodiesterase 4A inhibitor | |||
| 0.054 | 0.045 | 0.054 | Fibroblast growth factor 4 antagonist | |||
| 0.041 | 0.032 | 0.041 | Opioid kappa receptor agonist | |||
| 0.015 | 0.006 | 0.015 | Glutamate (mGluR6) agonist | |||
| 0.023 | 0.015 | 0.032 | Dopamine D1 agonist | 0.032 0.008 CID_18654381 | CID_18654381 | |
| 0.022 | 0.014 | 0.022 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.092 | 0.083 | 0.191 | DNA intercalator | 0.191 0.028 CID_18654381 | CID_18654381 | |
| 0.035 | 0.027 | 0.035 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.026 | 0.019 | 0.026 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.012 | 0.005 | 0.012 | Progesterone receptor A antagonist | |||
| 0.053 | 0.046 | 0.053 | EphB4 antagonist | |||
| 0.033 | 0.026 | 0.033 | Glutamate (mGluR4) agonist | |||
| 0.056 | 0.049 | 0.056 | Acetylcholine M5 receptor antagonist | |||
| 0.047 | 0.04 | 0.098 | Carbonic anhydrase XII inhibitor | 0.098 0.02 CID_18654381 | CID_18654381 | |
| 0.013 | 0.006 | 0.013 | Melatonin 2 antagonist | |||
| 0.017 | 0.011 | 0.017 | Carbonic anhydrase VIII inhibitor | |||
| 0.017 | 0.011 | 0.017 | Carbonic anhydrase X inhibitor | |||
| 0.079 | 0.072 | 0.079 | Antiadrenergic | |||
| 0.024 | 0.019 | 0.024 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.055 | 0.049 | 0.076 | Lipocortins synthesis agonist | 0.076 0.016 CID_18654381 | CID_18654381 | |
| 0.032 | 0.027 | 0.032 | Retinoid X alpha receptor agonist | |||
| 0.024 | 0.019 | 0.024 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.033 | 0.028 | 0.069 | Arginase inhibitor | 0.069 0.008 CID_18654381 | CID_18654381 | |
| 0.036 | 0.031 | 0.036 | Potassium channel Kv1.1 blocker | |||
| 0.082 | 0.078 | 0.082 | Platelet activating factor alpha antagonist | |||
| 0.03 | 0.026 | 0.03 | Sirtuin 2 inhibitor | |||
| 0.076 | 0.072 | 0.076 | Adrenaline antagonist | |||
| 0.071 | 0.067 | 0.071 | Acetylcholine nicotinic antagonist | |||
| 0.013 | 0.009 | 0.013 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.07 | 0.066 | 0.07 | Vanilloid 4 agonist | |||
| 0.015 | 0.011 | 0.015 | Purinergic P2Y1 agonist | |||
| 0.049 | 0.045 | 0.049 | Carbonic anhydrase II inhibitor | |||
| 0.116 | 0.113 | 0.116 | Cholinergic | |||
| 0.059 | 0.055 | 0.059 | Neuronal nicotinic receptor antagonist | |||
| 0.015 | 0.011 | 0.015 | Thromboxane A2 agonist | |||
| 0.012 | 0.008 | 0.012 | Egl nine homolog 3 inhibitor | |||
| 0.028 | 0.025 | 0.028 | Prostaglandin agonist | |||
| 0.083 | 0.08 | 0.083 | Protein kinase (CK2) inhibitor | |||
| 0.071 | 0.068 | 0.071 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.039 | 0.035 | 0.039 | Leukocyte elastase inhibitor | |||
| 0.045 | 0.042 | 0.045 | Potassium channel (Inward rectifier) blocker | |||
| 0.032 | 0.029 | 0.032 | Retinoid X alpha receptor antagonist | |||
| 0.018 | 0.015 | 0.018 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.062 | 0.059 | 0.062 | Alpha 1b adrenoreceptor antagonist | |||
| 0.145 | 0.142 | 0.145 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.024 | 0.022 | 0.024 | CXC chemokine 2 receptor antagonist | |||
| 0.045 | 0.043 | 0.045 | HCV NS3/NS4A protease inhibitor | |||
| 0.023 | 0.022 | 0.023 | Sigma 2 receptor antagonist | |||
| 0.076 | 0.075 | 0.076 | Histamine H2 receptor antagonist | |||
| 0.027 | 0.026 | 0.027 | Liver X receptor antagonist | |||
| 0.008 | 0.007 | 0.008 | Thyroid hormone beta agonist | |||
| 0.05 | 0.049 | 0.05 | Thromboxane synthase inhibitor | |||
| 0.025 | 0.024 | 0.025 | Cyclin E2 inhibitor | |||
| 0.144 | 0.144 | 0.381 | Hypolipemic | 0.381 0.029 CID_18654381 | CID_18654381 | |
| 0.046 | 0.046 | 0.07 | Carbonic anhydrase IX inhibitor | 0.07 0.032 CID_18654381 | CID_18654381 | |
| 0.009 | 0.01 | 0.014 | Purinergic P2Y2 agonist | 0.014 0.004 CID_18654381 | CID_18654381 | |
| 0.024 | 0.034 | 0.032 | 1,3-Beta-glucan synthase inhibitor | 0.032 0.01 CID_18654381 | CID_18654381 | |
| 0.108 | 0.12 | 0.257 | Diuretic | 0.257 0.029 CID_18654381 | CID_18654381 | |
| 0.016 | 0.029 | 0.022 | Leukotriene B4 receptor 2 antagonist | 0.022 0.015 CID_18654381 | CID_18654381 | |
| 0.129 | 0.143 | 0.136 | Lipocortins synthesis antagonist | 0.136 0.128 CID_18654381 | CID_18654381 | |
| 0.047 | 0.061 | 0.112 | Neuraminidase inhibitor | 0.112 0.012 CID_18654381 | CID_18654381 | |
| 0.032 | 0.049 | 0.126 | Phosphorylase inhibitor | 0.126 0.009 CID_18654381 | CID_18654381 | |
| 0.022 | 0.039 | 0.043 | Toll-Like receptor 4 agonist | 0.043 0.004 CID_18654381 | CID_18654381 | |
| 0.049 | 0.071 | 0.066 | Transcription factor AP-1 inhibitor | 0.066 0.035 CID_18654381 | CID_18654381 | |
| 0.026 | 0.055 | 0.098 | Antibiotic Aminoglycoside-like | 0.098 0.003 CID_18654381 | CID_18654381 | |
| 0.039 | 0.068 | 0.071 | Prostaglandin EP2 antagonist | 0.071 0.033 CID_18654381 | CID_18654381 | |
| 0.034 | 0.067 | 0.155 | Protein 50S ribosomal subunit inhibitor | 0.155 0.006 CID_18654381 | CID_18654381 | |
| 0.014 | 0.052 | 0.077 | Protein 30S ribosomal subunit inhibitor | 0.077 0.004 CID_18654381 | CID_18654381 | |
| 0.003 | 0.049 | 0.019 | Antibiotic Macrolide-like | 0.019 0.007 CID_18654381 | CID_18654381 | |
| 0.01 | 0.06 | 0.021 | Corticosteroid-like | 0.021 0.014 CID_18654381 | CID_18654381 | |
| 0.06 | 0.109 | 0.132 | Falcipain 2 inhibitor | 0.132 0.037 CID_18654381 | CID_18654381 | |
| 0.061 | 0.113 | 0.134 | Falcipain inhibitor | 0.134 0.038 CID_18654381 | CID_18654381 | |
| 0.003 | 0.056 | 0.013 | Purinergic receptor agonist | 0.013 0.012 CID_18654381 | CID_18654381 | |
| 0.003 | 0.056 | 0.013 | Purinergic P2 agonist | 0.013 0.012 CID_18654381 | CID_18654381 | |
| 0.091 | 0.146 | 0.39 | Thrombolytic | 0.39 0.012 CID_18654381 | CID_18654381 | |
| 0.078 | 0.133 | 0.095 | Folate antagonist | 0.095 0.074 CID_18654381 | CID_18654381 | |
| 0.033 | 0.094 | 0.472 | Selectin antagonist | 0.472 0.003 CID_18654381 | CID_18654381 | |
| 0.009 | 0.071 | 0.059 | Squalene synthetase inhibitor | 0.059 0.012 CID_18654381 | CID_18654381 | |
| 0.206 | 0.268 | 0.849 | Cyclophilin D inhibitor | 0.849 0.005 CID_18654381 | CID_18654381 | |
| 0.027 | 0.091 | 0.065 | Neuraminidase (Influenza A) inhibitor | 0.065 0.009 CID_18654381 | CID_18654381 | |
| 0.079 | 0.154 | 0.417 | Cell adhesion inhibitor | 0.417 0.005 CID_18654381 | CID_18654381 | |
| 0.026 | 0.105 | 0.055 | Microtubule stabilization | 0.055 0.021 CID_18654381 | CID_18654381 | |
| 0.007 | 0.087 | 0.014 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.014 0.012 CID_18654381 | CID_18654381 | |
| 0.029 | 0.125 | 0.12 | Factor IXa inhibitor | 0.12 0.006 CID_18654381 | CID_18654381 | |
| 0.03 | 0.128 | 0.084 | Nitric oxide donor | 0.084 0.019 CID_18654381 | CID_18654381 | |
| 0.062 | 0.192 | 0.107 | T cell inhibitor | 0.107 0.02 CID_18654381 | CID_18654381 | |
| 0.094 | 0.233 | 0.396 | Platelet antagonist | 0.396 0.028 CID_18654381 | CID_18654381 | |
| 0.045 | 0.195 | 0.239 | Cell adhesion molecule inhibitor | 0.239 0.007 CID_18654381 | CID_18654381 | |
| 0.02 | 0.264 | 0.073 | DNA gyrase inhibitor | 0.073 0.032 CID_18654381 | CID_18654381 | |
| 0.006 | 0.323 | 0.03 | Motilin receptor agonist | 0.03 0.01 CID_18654381 | CID_18654381 | |
| 0.005 | 0.393 | 0.017 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.017 0.012 CID_18654381 | CID_18654381 | |
| 0.018 | 0.562 | 0.286 | Anticoagulant | 0.286 0.031 CID_18654381 | CID_18654381 | |
| 0.033 | 0.622 | 0.232 | Antiobesity | 0.232 0.174 CID_18654381 | CID_18654381 | |
| 0.033 | 0.689 | 0.492 | Immunomodulator | 0.492 0.024 CID_18654381 | CID_18654381 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |